logo

iStock Rating

F
Details...
Enter Symbol click to research

Express Scripts, Inc. (NASDAQ: ESRX)

Sector: Medical

Current Price : $55.43

52 Week Low
$50.0552 Week High
$65.45
 

EXPRESS SC(NSDQ:ESRX)
Express Scripts, Inc. is one of the largest pharmacy benefit management companies in North America. Through facilities in the states and Canada, the company serves thousands of client groups, including managed care organizations, insurance carriers, third-party administrators, employers and union-sponsored benefit plans.
# Employees: 13120
Address: ONE EXPRESS WAY,ST. LOUIS,MO,USA
Phone: 314-692-1983
Fax: 314-291-3669
Website: www.express-scripts.com
Email: investor.relations@express-scripts.com
Sector: Medical
Industry: Medical Services
Executive Officers
George Paz (Chairman; President and Chief Executive Officer)
Jeffrey Hall (Executive Vice President and Chief Financial Offic)
Keith Ebling (Executive Vice President; General Counsel and Secr)
Edward Ignaczak (Executive Vice President; Sales and Marketing)
Patrick McNamee (Executive Vice President; Chief Operating Officer,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 12/31/2012
Next Earnings Date(Expected): 5/9/2013
Mean EPS (Next Qtr): $1.05
Mean EPS (Year): $4.27
Mean Estimate(Long Term): $15.11
P/E Ratio(Based on EPS estimate): 12.970
Number of Estimates: 14
Shares Performance
Period esrx Compare to S&P
YTD 2.50 % -6.01 %
4 Weeks -4.45 % -4.35 %
12 Weeks 2.20 % -1.24 %
Shares Information
Analyst Coverage: Y
Avg Volume: 4445912
Shares Outstanding: 818M
Market Cap: $45.30B
52 Week High: $65.45
52 Week Low: $50.05
P/E Ratio: 15.040
PEG Ratio: 0.860
Split: On 6/8/2010 esrx split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 2.94 %
EPS Growth in Last Year: 28.05 %
Sales Growth in Last Quarter: 1.52 %
Sales Growth in Last Quarter: 126.51 %
Financials
Qtr Book Value: $1.93
Cash Flow/Share: $9.68
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Home | Login |Research | Earnings | Scans | Charts | Submit Article | Join Blog Network | Advertise | Subscribe to RSS

Terms of Use | Privacy Policy | Copyright 2012 all rights reserved
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.